New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
06:59 EDTOREXOrexigen to host conference call
Conference call to discuss three month extension of FDA NB32 review will be held on June 11 at 8 am. Webcast Link
News For OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
17:43 EDTOREXOrexigen in manufacturing pact with Mallinckrodt for naltrexone
Subscribe for More Information
May 27, 2015
17:49 EDTOREXZosano Pharma elects Orexigen's Joseph Hagan to board of directors
Zosano Pharma (ZSAN) announced earlier the election of Joseph Hagan to its board of directors, effective May 22. Hagan is EVP, Chief Business & Financial Officer of Orexigen Therapeutics (OREX). Bruce Steel, chairman of Zosano, remarked that Hagan is "a seasoned business and financial executive with a significant track record in complex partnerships and transactions who will add additional breadth of perspective to our board as Zosano advances its clinical development programs in osteoporosis, hypoglycemia and migraine."
May 21, 2015
10:12 EDTOREXOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use